Fidelity Investments
JAZZ icon

Fidelity Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$58.1M Sell
547,527
-213,975
-28% -$22.7M ﹤0.01% 1338
2025
Q1
$94.5M Buy
761,502
+19,197
+3% +$2.38M 0.01% 1117
2024
Q4
$91.4M Sell
742,305
-93,576
-11% -$11.5M 0.01% 1154
2024
Q3
$93.1M Sell
835,881
-87,943
-10% -$9.8M 0.01% 1131
2024
Q2
$98.6M Sell
923,824
-36,555
-4% -$3.9M 0.01% 1044
2024
Q1
$116M Sell
960,379
-268,612
-22% -$32.3M 0.01% 997
2023
Q4
$151M Sell
1,228,991
-104,138
-8% -$12.8M 0.01% 859
2023
Q3
$173M Buy
1,333,129
+100,349
+8% +$13M 0.01% 760
2023
Q2
$153M Buy
1,232,780
+126,616
+11% +$15.7M 0.01% 829
2023
Q1
$162M Sell
1,106,164
-199,482
-15% -$29.2M 0.01% 795
2022
Q4
$208M Buy
1,305,646
+99,953
+8% +$15.9M 0.02% 663
2022
Q3
$161M Sell
1,205,693
-394,811
-25% -$52.6M 0.02% 758
2022
Q2
$250M Sell
1,600,504
-153,373
-9% -$23.9M 0.02% 620
2022
Q1
$273M Buy
1,753,877
+110,633
+7% +$17.2M 0.02% 663
2021
Q4
$209M Sell
1,643,244
-1,473,348
-47% -$188M 0.02% 789
2021
Q3
$406M Sell
3,116,592
-328,811
-10% -$42.8M 0.03% 506
2021
Q2
$612M Sell
3,445,403
-89,654
-3% -$15.9M 0.05% 371
2021
Q1
$581M Buy
3,535,057
+666,338
+23% +$110M 0.05% 379
2020
Q4
$473M Buy
2,868,719
+87,803
+3% +$14.5M 0.04% 424
2020
Q3
$397M Buy
2,780,916
+1,185,464
+74% +$169M 0.04% 390
2020
Q2
$176M Buy
1,595,452
+94,313
+6% +$10.4M 0.02% 657
2020
Q1
$150M Buy
1,501,139
+112,997
+8% +$11.3M 0.02% 610
2019
Q4
$207M Sell
1,388,142
-437,858
-24% -$65.4M 0.02% 636
2019
Q3
$234M Sell
1,826,000
-1,033,344
-36% -$132M 0.03% 578
2019
Q2
$408M Sell
2,859,344
-554,315
-16% -$79M 0.05% 381
2019
Q1
$488M Sell
3,413,659
-1,177,608
-26% -$168M 0.06% 315
2018
Q4
$569M Sell
4,591,267
-1,157,476
-20% -$143M 0.08% 247
2018
Q3
$967M Sell
5,748,743
-886,215
-13% -$149M 0.11% 172
2018
Q2
$1.14B Buy
6,634,958
+715,595
+12% +$123M 0.13% 150
2018
Q1
$894M Sell
5,919,363
-966,529
-14% -$146M 0.11% 191
2017
Q4
$927M Sell
6,885,892
-1,156,692
-14% -$156M 0.11% 196
2017
Q3
$1.18B Sell
8,042,584
-247,826
-3% -$36.2M 0.14% 142
2017
Q2
$1.29B Buy
8,290,410
+849,348
+11% +$132M 0.16% 125
2017
Q1
$1.08B Sell
7,441,062
-24,553
-0.3% -$3.56M 0.14% 153
2016
Q4
$814M Sell
7,465,615
-1,293,068
-15% -$141M 0.11% 197
2016
Q3
$1.06B Sell
8,758,683
-45,794
-0.5% -$5.56M 0.14% 152
2016
Q2
$1.24B Sell
8,804,477
-113,017
-1% -$16M 0.17% 126
2016
Q1
$1.16B Sell
8,917,494
-158,066
-2% -$20.6M 0.16% 128
2015
Q4
$1.28B Sell
9,075,560
-50,649
-0.6% -$7.12M 0.17% 120
2015
Q3
$1.21B Buy
9,126,209
+159,098
+2% +$21.1M 0.17% 122
2015
Q2
$1.58B Buy
8,967,111
+30,862
+0.3% +$5.43M 0.2% 99
2015
Q1
$1.54B Buy
8,936,249
+24,899
+0.3% +$4.3M 0.2% 110
2014
Q4
$1.46B Buy
8,911,350
+260,983
+3% +$42.7M 0.19% 113
2014
Q3
$1.39B Buy
8,650,367
+2,710,013
+46% +$435M 0.19% 113
2014
Q2
$873M Buy
5,940,354
+367,562
+7% +$54M 0.12% 184
2014
Q1
$773M Buy
5,572,792
+654,085
+13% +$90.7M 0.11% 198
2013
Q4
$623M Buy
4,918,707
+466,009
+10% +$59M 0.09% 254
2013
Q3
$410M Buy
4,452,698
+642,501
+17% +$59.1M 0.06% 354
2013
Q2
$262M Buy
+3,810,197
New +$262M 0.04% 477